Home » Topics » exelixis inc
Exelixis thyroid cancer drug meets late-stage goal
(Reuters) – Exelixis Inc said a late-stage trial of its experimental thyroid cancer drug met the main goal of improving survival of patients without disease progression, compared with a dummy drug. The drug cabozantinib significantly improved median progression-free survival (PFS) by 7.2 months compared with a placebo. The median PFS…
Brand new on Raw Story
- ‘March Against Monsanto’ protests attract millions worldwide
- John Kerry tells Egyptian president: Show us your reforms
- Visa and Mastercard ask federal court to legalize transaction fees
- Rights group urges United Arab Emirates not to deport striking immigrants
- Scientist slams Stanford for ‘outrageous’ fertility patent
- Three more suspects and suspects’ friend arrested in London ‘beheading’ case
- Syrian opposition say kidnapped bishops are ‘in good health’
- Top chefs say Latin America will become culinary superpower
- Florida squatter found with more than a dozen dead cats in freezer
- Documentary on Khmer Rouge atrocities wins top award at Cannes
Commentary
On Memorial Day, it’s time to make sure our veterans suffering from burn pit diseases get the care they need
By Nora Eisenberg
![["Men's Tears. Marine U.S. Army In Sorrow. Soldier'S Longing. Love Of Country. Sadness For The Victims" on Shutterstock]](http://www.rawstory.com/rs/wp-content/uploads/2013/05/sad-soldier-shutterstock-230x105.jpg "sad soldier shutterstock")
Sexual harasser learns same old excuses don’t work anymore
By Amanda Marcotte
The real problem with 'check your privilege': It’s too generous
By Amanda Marcotte
Raw Exclusives
Featured Video
Follow Us!
